BARDA Further Funds Inflammatix ViraBac EZ Acute Infection Test
This additional BARDA funding supports a test designed to read the immune system and rapidly diagnose acute infection at the point of care.
Read MorePosted by Melanie Hamilton-Basich | Nov 16, 2020 | Immunoassay, POC Rapid Assays |
This additional BARDA funding supports a test designed to read the immune system and rapidly diagnose acute infection at the point of care.
Read MorePosted by Melanie Hamilton-Basich | Nov 13, 2020 | Covid 19 |
The contract enables InBios to ramp up production of the covid-19 tests to 400,000 units per week – 20 times the facility’s current output – by May 2021.
Read MorePosted by Laurie Bonner | Nov 12, 2020 | Covid 19, Point-of-Care |
The BD Veritor Plus System has been authorized for use by Health Canada under an interim order.
Read MorePosted by Laurie Bonner | Nov 9, 2020 | Immunoassay Instrumentation, POC Instruments |
The microplate reader can be retrofitted for point-of-care clinical testing at urgent care facilities, hospitals, or physicians’ offices.
Read MorePosted by Melanie Hamilton-Basich | Nov 6, 2020 | Covid 19 |
Experts say increased use and uneven reporting of positive antigen tests will likely cause undercounting of covid-19 cases.
Read More